0
Signin
countryflagCA

888-969-2592

RY 135.4 1.0674% TD 80.36 -0.4953% SHOP 98.5 1.7037% CNR 166.9 0.2402% ENB 49.76 1.5717% CP 108.92 2.0232% BMO 122.77 -0.4621% TRI 221.91 6.4776% CNQ 102.79 -0.2233% BN 56.78 0.7273% ATD 74.89 -1.1484% CSU 3550.9399 -1.8182% BNS 63.52 -0.2513% CM 64.62 0.1705% SU 52.33 1.0427% TRP 49.85 1.4242% NGT 56.3 0.7516% WCN 223.06 0.0179% MFC 32.46 0.0925% BCE 45.15 -1.333%

Viemed Healthcare Inc

Healthcare CA VMD

NoneCAD
-(-%)

Last update at 2024-01-23T20:03:10.600004Z

Day Range

--
LowHigh

52 Week Range

8.1416.25
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 8.99M 12.50M 26.36M 8.80M 10.34M
Minority interest - - - - -
Net income 6.22M 9.13M 31.53M 8.53M 10.18M
Selling general administrative 73.36M 60.04M 57.71M 45.27M 30.68M
Selling and marketing expenses - - - - 0.27M
Gross profit 84.68M 73.41M 80.11M 56.01M 48.58M
Reconciled depreciation 15.63M 11.31M 9.58M 6.40M 3.78M
Ebit 8.25M 11.58M 26.78M 8.75M 10.52M
Ebitda 24.57M 23.79M 34.13M 15.62M 14.30M
Depreciation and amortization 16.32M 12.21M 7.34M 6.87M 3.78M
Non operating income net other - - - - -
Operating income 8.25M 11.58M 26.78M 8.75M 17.05M
Other operating expenses 130.23M 105.03M 106.86M 71.04M 48.23M
Interest expense 0.20M 0.32M 0.51M 0.31M 0.18M
Tax provision 2.77M 3.38M -5.16700M 0.27M 0.16M
Interest income 0.74M 0.92M 0.42M 0.31M 0.18M
Net interest income -0.19700M -0.31800M -0.50900M -0.31400M -0.18100M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 2.77M 3.38M -5.16700M 0.27M 0.16M
Total revenue 138.83M 117.06M 131.31M 80.26M 65.27M
Total operating expenses 76.08M 61.38M 55.66M 46.79M 31.54M
Cost of revenue 54.15M 43.65M 51.20M 24.25M 16.69M
Total other income expense net 0.74M 0.92M -0.41800M 0.05M -6.70600M
Discontinued operations - - - - -
Net income from continuing ops 6.22M 9.13M 31.53M 8.53M 10.18M
Net income applicable to common shares 6.22M 9.13M 31.53M 8.53M 9.51M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 117.04M 117.96M 112.56M 82.60M 53.52M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 3.85M 1.73M 1.51M 1.56M 0.82M
Total liab 19.95M 23.14M 30.87M 38.90M 18.49M
Total stockholder equity 97.09M 94.82M 81.69M 43.70M 35.03M
Deferred long term liab - - - - -
Other current liab 11.09M 8.88M 12.94M 9.05M 7.91M
Common stock 15.12M 14.01M 9.18M 3.37M 0.07M
Capital stock 15.12M 14.01M 9.18M 3.37M 0.07M
Retained earnings 69.85M 73.33M 65.64M 34.11M 29.57M
Other liab 0.89M 0.56M 0.86M 2.32M 1.12M
Good will - - - - -
Other assets 4.71M 5.65M 9.60M 0.01M 0.00000M
Cash 16.91M 28.41M 30.98M 13.36M 10.41M
Cash and equivalents 11.00M 16.46M 30.98M 13.36M 10.41M
Total current liabilities 18.86M 17.81M 23.02M 25.91M 16.98M
Current deferred revenue 4.62M 3.75M 3.41M 3.31M -
Net debt -16.22000M -21.89000M -19.84600M 6.16M -6.98800M
Short term debt 0.49M 1.94M 4.58M 8.84M 3.03M
Short long term debt - 1.48M 1.84M 1.75M -
Short long term debt total 0.69M 6.52M 11.13M 19.51M 3.42M
Other stockholder equity 12.12M 7.75M 7.32M 6.38M 5.39M
Property plant equipment 68.44M 62.85M 55.06M 54.77M 30.56M
Total current assets 39.74M 47.31M 47.17M 27.81M 22.96M
Long term investments 4.16M 2.16M 0.73M - -
Net tangible assets 97.09M 94.82M 81.69M 43.70M 32.57M
Short term investments - - - - -
Net receivables 15.40M 14.72M 12.37M 11.53M 12.07M
Long term debt 0.00000M 4.31M 5.80M 7.63M 0.00000M
Inventory 3.57M 2.46M 2.31M 1.36M 2.89M
Accounts payable 2.65M 3.24M 2.10M 4.70M 5.88M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - -0.27800M -0.45100M -0.15700M -8.82200M
Additional paid in capital - - - - -
Common stock total equity - - 9.18M 3.37M 0.07M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 1.59M 0.86M 0.86M 0.01M 30.56M
Deferred long term asset charges - - - - -
Non current assets total 77.30M 70.65M 65.39M 54.78M 30.56M
Capital lease obligations 0.69M 0.73M 3.50M 10.13M 3.42M
Long term debt total 0.20M 4.57M 6.56M 10.67M 0.39M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -23.97600M -0.59900M -8.41500M -12.81100M -5.30100M
Change to liabilities 0.55M 0.48M 0.31M 1.51M 3.31M
Total cashflows from investing activities -23.97600M -19.74600M -8.41500M -12.81100M -5.30100M
Net borrowings -5.83800M -3.99900M -10.94500M -2.20800M -10.16200M
Total cash from financing activities -15.26600M -5.32100M -9.06900M -3.33400M -11.75200M
Change to operating activities -0.28900M -4.24800M 1.50M 1.73M 3.11M
Net income 6.22M 9.13M 31.53M 8.53M 10.18M
Change in cash -11.49400M -2.57300M 17.63M 2.94M 5.32M
Begin period cash flow 28.41M 30.98M 13.36M 10.41M 5.10M
End period cash flow 16.91M 28.41M 30.98M 13.36M 10.41M
Total cash from operating activities 27.75M 22.49M 35.11M 19.09M 22.37M
Issuance of capital stock - - - - -
Depreciation 15.63M 11.31M 9.58M 6.40M 3.78M
Other cashflows from investing activities -1.07800M -0.00300M 4.63M 0.57M 0.81M
Dividends paid - - - - -
Change to inventory 0.30M -0.21200M -2.30300M -0.30600M -1.25400M
Change to account receivables -12.56700M -7.34500M -9.95500M -12.50600M -5.25300M
Sale purchase of stock -9.71100M -1.43400M 1.88M -1.52200M -1.59400M
Other cashflows from financing activities 0.28M 0.11M 1.88M 10.23M 0.00400M
Change to netincome 16.03M 15.62M 4.20M 13.80M 9.16M
Capital expenditures 22.90M 19.74M 13.04M 13.38M 6.11M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -10.13500M -13.56100M -10.20100M -9.53200M -0.74800M
Stock based compensation 5.20M 5.15M 4.88M 3.89M 2.70M
Other non cash items 9.08M 6.58M 16.10M 9.81M 6.45M
Free cash flow 4.85M 2.75M 22.07M 5.70M 16.25M

Fundamentals

  • Previous Close -
  • Market Cap402.21M
  • VolumeNone
  • P/E Ratio32.66
  • Dividend Yield-%
  • EBITDA33.52M
  • Revenue TTM169.78M
  • Revenue Per Share TTM4.44
  • Gross Profit TTM 84.68M
  • Diluted EPS TTM0.32

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
VMD
Viemed Healthcare Inc		 - -% - 32.66 16.72 2.30 2.69 2.31 11.74
QIPT
Quipt Home Medical Corp.		 0.47 9.36% 5.49 - - - -
PRN
Profound Medical Corp		 0.04 0.40% 10.09 - - 40.82 5.05 35.48 -9.6771
HTL
Hamilton Thorne Ltd.		 0.01 0.72% 1.39 - - - -
TMD
Titan Medical Inc		 - -% 0.06 - - 0.59 2.03 0.54 -0.3059

Reports Covered

Stock Research & News

View All

Profile

Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

Viemed Healthcare Inc

625 East Kaliste Saloom Road, Lafayette, LA, United States, 70508

Key Executives

Name Title Year Born
Mr. Casey Hoyt CEO & Director 1977
Mr. Michael B. Moore CRT Pres 1978
Mr. Trae Paul Fitzgerald Chief Financial Officer 1989
Mr. William Todd Zehnder COO & Director 1975
Dr. William Dana Frazier M.D. Chief Medical Officer & Director 1958
Mr. Jeremy Trahan Chief Legal Officer and Exec. VP of Acquisitions & Strategic Transactions NA
Mr. Patrick Eagan Gen. Counsel 1979
Mr. Michael Freeman Chief Bus. Devel. Officer NA
Mr. Robert Grossman LLB Corp. Sec. 1974

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).